A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

NCT00048204 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

372

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: GW597599B
DRUG: paroxetine

Sponsor

GlaxoSmithKline